Mylan/Biocon Herceptin biosimilar faces EU delay
EU inspectors require re-inspection of Bangalore plant.
EU inspectors require re-inspection of Bangalore plant.
Deal with Roche paves way for near-copy of breast cancer blockbuster
First Herceptin biosimilar filed in EU, companies say.